181 results on '"Frézard, Frédéric"'
Search Results
2. Oral formulation of Wnt inhibitor complex reduces inflammation and fibrosis in intraperitoneal implants in vivo
3. Ionizable Lipid Nanoparticle-Mediated TRAIL mRNA Delivery in the Tumor Microenvironment to Inhibit Colon Cancer Progression
4. Comparative evaluation of meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes and immunotherapy using an anti-canine IL-10 receptor-blocking monoclonal antibody on canine visceral leishmaniasis
5. Susceptibility of Leishmania to novel pentavalent organometallics: Investigating impact on DNA and membrane integrity in antimony(III)‐sensitive and ‐resistant strains.
6. Antileishmanial activity of fullerol and its liposomal formulation in experimental models of visceral leishmaniasis
7. Development and characterization of liposomal formulations containing sesquiterpene lactones for the treatment of chronic gout.
8. Distearoyl phosphatidylglycerol and dioleoyl phosphatidylglycerol increase the retention and reduce the toxicity of amphotericin B-loaded in nanoemulsions.
9. Combination oral therapy against Leishmania amazonensis infection in BALB/c mice using nanoassemblies made from amphiphilic antimony(V) complex incorporating miltefosine
10. GABA-containing liposomes: neuroscience applications and translational perspectives for targeting neurological diseases
11. Redox-Active Metal Complexes in Trypanosomatids
12. Liposomal Amphotericin B for Treatment of Leishmaniasis: From the Identification of Critical Physicochemical Attributes to the Design of Effective Topical and Oral Formulations
13. α-Tocopherol succinate improves encapsulation and anticancer activity of doxorubicin loaded in solid lipid nanoparticles
14. Cytotoxicity and apoptotic activity of novel organobismuth(V) and organoantimony(V) complexes in different cancer cell lines
15. Membranes, Vesicles, and Other Supramolecular Systems Made from Fluorinated Amphiphiles
16. Organometallic Compounds in Chemotherapy Against Leishmania
17. Growth arrested live-attenuated Leishmania infantum KHARON1 null mutants display cytokinesis defect and protective immunity in mice
18. Nanoemulsions loaded with amphotericin B: A new approach for the treatment of leishmaniasis
19. Nanoassemblies from Amphiphilic Sb Complexes Target Infection Sites in Models of Visceral and Cutaneous Leishmaniases
20. Cholesterol improves stability of amphotericin B nanoemulsion: promising use in the treatment of cutaneous leishmaniasis
21. Ionizable Lipid Nanoparticle-Mediated Delivery of Plasmid DNA in Cardiomyocytes
22. Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes
23. List of Contributors
24. Nanostructures for Improved Antimonial Therapy of Leishmaniasis
25. The Potential of 2-Substituted Quinolines as Antileishmanial Drug Candidates
26. Liposomal Amphotericin B for Treatment of Leishmaniasis: From the Identification of Critical Physicochemical Attributes to the Design of Effective Topical and Oral Formulations.
27. Synthesis and characterization of bismuth(III) and antimony(V) porphyrins: high antileishmanial activity against antimony-resistant parasite
28. Nanocarriers for Improved Delivery of Angiotensin-(1-7)
29. Contributors
30. A TLR9-adjuvanted vaccine formulated into dissolvable microneedle patches or cationic liposomes protects against leishmaniasis after skin or subcutaneous immunization
31. Therapeutic Efficacy of a Mixed Formulation of Conventional and PEGylated Liposomes Containing Meglumine Antimoniate, Combined with Allopurinol, in Dogs Naturally Infected with Leishmania infantum
32. Preclinical Gold Complexes as Oral Drug Candidates to Treat Leishmaniasis Are Potent Trypanothione Reductase Inhibitors
33. Use of liposomal nanoformulations in antileishmania therapy: challenges and perspectives
34. Reactive oxygen species generating photosynthesized ferromagnetic iron oxide nanorods as promising antileishmanial agent
35. Nanostructured Systems Improve the Antimicrobial Potential of the Essential Oil from Cymbopogon densiflorus Leaves
36. Corrigendum: Characterization of Aspergillus fumigatus Extracellular Vesicles and Their Effects on Macrophages and Neutrophils Functions
37. Liposomes for drug delivery in stroke
38. Characterization of Aspergillus fumigatus Extracellular Vesicles and Their Effects on Macrophages and Neutrophils Functions
39. Recent advances in amphotericin B delivery strategies for the treatment of leishmaniases
40. Nanostructured Systems Improve the Antimicrobial Potential of the Essential Oil from Leaves.
41. Use of liposomal nanoformulations in antileishmania therapy: challenges and perspectives.
42. Injectable Liposomal Formulations: Systematic Analysis for Regulatory Purposes
43. Canine Leishmaniasis: An Overview of the Current Status and Strategies for Control
44. In vitro antileishmanial activity of leaf and stem extracts of seven Brazilian plant species
45. American tegumentary leishmaniasis in Brazil: a critical review of the current therapeutic approach with systemic meglumine antimoniate and short‐term possibilities for an alternative treatment
46. GoldLeish: gold(I) Complexes as Oral Drug Candidates to Treat Leishmaniasis are Potent Trypanothione Reductase Inhibitors and Exert in vivo Efficacy
47. Antimony resistance in Leishmania (Viannia) braziliensis clinical isolates from atypical lesions associates with increased ARM56/ARM58 transcripts and reduced drug uptake
48. Seasonality study of essential oil from leaves of Cymbopogon densiflorus and nanoemulsion development with antioxidant activity
49. Efficacy of Meglumine Antimoniate in a Low Polymerization State Orally Administered in a Murine Model of Visceral Leishmaniasis
50. Chapter 22 - Nanostructures for Improved Antimonial Therapy of Leishmaniasis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.